Geode Capital Management
ITCI

Geode Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,831,951
Closed -$242M 4573
2025
Q1
$242M Buy
1,831,951
+115,122
+7% +$15.2M 0.02% 579
2024
Q4
$143M Buy
1,716,829
+8,528
+0.5% +$712K 0.01% 774
2024
Q3
$125M Buy
1,708,301
+22,128
+1% +$1.62M 0.01% 839
2024
Q2
$116M Sell
1,686,173
-379,125
-18% -$26M 0.01% 837
2024
Q1
$143M Buy
2,065,298
+63,507
+3% +$4.4M 0.01% 732
2023
Q4
$143M Buy
2,001,791
+90,769
+5% +$6.5M 0.02% 675
2023
Q3
$99.6M Buy
1,911,022
+74,265
+4% +$3.87M 0.01% 796
2023
Q2
$116M Buy
1,836,757
+87,739
+5% +$5.56M 0.01% 705
2023
Q1
$94.7M Buy
1,749,018
+77,581
+5% +$4.2M 0.01% 776
2022
Q4
$88.5M Buy
1,671,437
+53,127
+3% +$2.81M 0.01% 782
2022
Q3
$75.3M Buy
1,618,310
+29,911
+2% +$1.39M 0.01% 818
2022
Q2
$90.7M Buy
1,588,399
+117,442
+8% +$6.7M 0.01% 729
2022
Q1
$90M Buy
1,470,957
+185,143
+14% +$11.3M 0.01% 839
2021
Q4
$67.3M Buy
1,285,814
+13,094
+1% +$685K 0.01% 1082
2021
Q3
$47.4M Buy
1,272,720
+19,518
+2% +$728K 0.01% 1323
2021
Q2
$51.2M Buy
1,253,202
+58,449
+5% +$2.39M 0.01% 1286
2021
Q1
$40.5M Buy
1,194,753
+86,757
+8% +$2.94M 0.01% 1393
2020
Q4
$35.2M Buy
1,107,996
+104,632
+10% +$3.33M 0.01% 1361
2020
Q3
$25.7M Buy
1,003,364
+160,340
+19% +$4.11M 0.01% 1337
2020
Q2
$21.6M Buy
843,024
+36,422
+5% +$935K ﹤0.01% 1460
2020
Q1
$12.4M Buy
806,602
+167,104
+26% +$2.57M ﹤0.01% 1607
2019
Q4
$21.9M Sell
639,498
-12,873
-2% -$442K ﹤0.01% 1513
2019
Q3
$4.87M Buy
652,371
+7,957
+1% +$59.4K ﹤0.01% 2395
2019
Q2
$8.36M Buy
644,414
+31,800
+5% +$413K ﹤0.01% 2072
2019
Q1
$7.46M Buy
612,614
+88,153
+17% +$1.07M ﹤0.01% 2093
2018
Q4
$5.97M Buy
524,461
+25,588
+5% +$291K ﹤0.01% 2109
2018
Q3
$10.8M Buy
498,873
+29,754
+6% +$646K ﹤0.01% 1860
2018
Q2
$8.29M Buy
469,119
+51,863
+12% +$916K ﹤0.01% 2024
2018
Q1
$8.78M Buy
417,256
+16,062
+4% +$338K ﹤0.01% 1856
2017
Q4
$5.81M Buy
401,194
+64,005
+19% +$927K ﹤0.01% 2118
2017
Q3
$5.32M Buy
337,189
+50,659
+18% +$799K ﹤0.01% 2171
2017
Q2
$3.56M Buy
286,530
+15,748
+6% +$196K ﹤0.01% 2382
2017
Q1
$4.4M Buy
270,782
+8,023
+3% +$130K ﹤0.01% 2191
2016
Q4
$3.97M Buy
262,759
+15,767
+6% +$238K ﹤0.01% 2208
2016
Q3
$3.76M Buy
246,992
+26,193
+12% +$399K ﹤0.01% 2146
2016
Q2
$8.57M Buy
220,799
+15,863
+8% +$616K ﹤0.01% 1553
2016
Q1
$5.7K Buy
204,936
+11,301
+6% +$314 ﹤0.01% 1786
2015
Q4
$10.4M Buy
193,635
+25,312
+15% +$1.36M 0.01% 1353
2015
Q3
$6.74M Buy
168,323
+3,333
+2% +$133K ﹤0.01% 1634
2015
Q2
$5.27M Buy
164,990
+8,329
+5% +$266K ﹤0.01% 1853
2015
Q1
$3.74M Buy
156,661
+41,927
+37% +$1M ﹤0.01% 2033
2014
Q4
$2.03M Buy
114,734
+2,978
+3% +$52.6K ﹤0.01% 2425
2014
Q3
$1.53M Buy
111,756
+35,550
+47% +$487K ﹤0.01% 2524
2014
Q2
$1.28M Buy
76,206
+20,431
+37% +$344K ﹤0.01% 2640
2014
Q1
$1.01M Buy
+55,775
New +$1.01M ﹤0.01% 2791